SCHEMBL14778451

SCHEMBL14778451

CN(C)C(=O)c1cc(CC(=O)O)ccc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
CDC25B P30305 1/20 0.49
CASP6 P55212 1/20 0.49
RCE1 Q9Y256 1/20 0.49
KDM4E B2RXH2 5/20 0.44
HPGD P15428 5/20 0.44
HSD17B10 Q99714 5/20 0.44
MAPT P10636 4/20 0.44
GAA P10253 4/20 0.44
TSHR P16473 4/20 0.44
ALOX15 P16050 1/20 0.44
NFKB1 P19838 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
RGS12 O14924 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
APEX1 P27695 1/20 0.43
THPO P40225 1/20 0.43
BLM P54132 1/20 0.43
GNAI1 P63096 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3732606 0.83 ALDH1A1 (0.57) ALDH1A1CDC25BCASP6RCE1KDM4E
SCHEMBL22615007 0.81 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL23665805 0.77 RXRA (0.47) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL2598686 0.76 HPGD (0.46) ALDH1A1CASP6KDM4EHPGDHSD17B10
SCHEMBL2597757 0.76 HPGD (0.46) ALDH1A1CASP6KDM4EHPGDHSD17B10
SCHEMBL16179546 0.75 GAA (0.52) ALDH1A1CDC25BCASP6RCE1KDM4E
SCHEMBL1708822 0.75 KMT2A (0.57) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL11458731 0.75 MAPT (0.58) ALDH1A1CDC25BCASP6RCE1KDM4E
SCHEMBL3729057 0.75 ALDH1A1 (0.55) ALDH1A1CDC25BCASP6RCE1KDM4E
SCHEMBL1000171 0.75 GAA (0.55) ALDH1A1CDC25BCASP6RCE1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2571860-A1 2-PHENYL BENZOYLAMIDES Pfizer Inc (US) 2013-03-27 EP disclosed
US-20130072519-A1 2-PHENYL BENZOYLAMIDES CONN EDWARD LEE (US) 2013-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130072519-A1 2-PHENYL BENZOYLAMIDES APOB, MTTP, HADHB ALDH1A1 885/4885CDC25B 2848/4885CASP6 3096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.